TY - JOUR T1 - Concerns about subgroup analyses and reason for stopping remdesivir trial JF - Canadian Medical Association Journal JO - CMAJ SP - E389 LP - E389 DO - 10.1503/cmaj.81197 VL - 194 IS - 10 AU - Bharath Kumar Tirupakuzhi Vijayaraghavan Y1 - 2022/03/14 UR - http://www.cmaj.ca/content/194/10/E389.abstract ER -